Visikol is a New Jersey-based biotechnology company that provides contract research services such as 3D tissue imaging, cell culture and digital pathology. Visikol was founded in 2014. Visikol's headquarters is located in Hampton, New Jersey, USA 0882... Visikol's Co-Founder & CEO, Michael Johnson, currently has an approval
rating of 53%. Visikol's primary competitors are Organovo, AMSBIO, InSphero and 5 more.
There have been no acquisitions found related to Visikol
Recent investment data cannot be found related to Visikol